Response to Letter Regarding Article, "High-Density Substrate Mapping in Brugada Syndrome: Combined Role of Conduction and Repolarization Heterogeneities in Arrhythmogenesis"

被引：0
|
作者：
Lambiase, P. D. [1 ]
Ahmed, A. K. [1 ]
Ben-Simon, R. [1 ]
Chow, A. W. [1 ]
Lowe, M. D. [1 ]
McKenna, W. J. [1 ]
Ciaccio, E. J. [2 ]
Brugada, R. [3 ]
Lizotte, E. [3 ]
Chaubey [4 ]
机构：
[1] UCL, Heart Hosp, London, England
[2] Columbia Univ, New York, NY USA
[3] Montreal Gen Hosp, Montreal, PQ, Canada
[4] Kings Coll London, London WC2R 2LS, England
来源：
CIRCULATION | 2010年 / 121卷 / 11期
关键词：
RHYTHM;
D O I：
10.1161/CIR.0b013e3181d8d4b5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E249 / E249
页数：1
相关论文
共 35 条
  • [31] Response to letter regarding article, "high-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor"
    Theilmeier, Gregor
    Schmidt, Christoph
    Herrmann, Joerg
    Keul, Petra
    Schaefers, Michael
    Herrgott, Ilka
    Mersmann, Jan
    Larmann, Jan
    Hermann, Sven
    Stypmann, Joerg
    Schober, Otmar
    Hildebrand, Reinhard
    Schulz, Reiner
    Heusch, Gerd
    Haude, Michael
    Lipinski, Karin von Wnuck
    Herzog, Christine
    Schmitz, Martina
    Erbel, Raimund
    Chun, Jerold
    Levkau, Bodo
    CIRCULATION, 2007, 115 (14) : E394 - E394
  • [32] Response by Crotti et al to Letter Regarding Article, "Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?"
    Crotti, Lia
    Lahtinen, Annukka M.
    Spazzolini, Carla
    Mastantuono, Elisa
    Monti, Maria Cristina
    Morassutto, Caterina
    Parati, Gianfranco
    Heradien, Marshall
    Goosen, Althea
    Lichtner, Peter
    Meitinger, Thomas
    Brink, Paul A.
    Kontula, Kimmo
    Swan, Heikki
    Schwartz, Peter J.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2016, 9 (06) : 581 - 582
  • [33] Letter by Xia regarding article,"high-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor"
    Xia, Pu
    CIRCULATION, 2007, 115 (14) : E393 - E393
  • [34] Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial"
    Schwartz, Gregory G.
    Szarek, Michael
    Bittner, Vera A.
    Steg, P. Gabriel
    CIRCULATION, 2020, 142 (20) : E335 - E336
  • [35] Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT"
    Bohula, Erin A.
    Giugliano, Robert P.
    Cannon, Christopher P.
    Zhou, Jing
    Murphy, Sabina A.
    White, Jennifer
    Tershakovec, Andrew M.
    Blazing, Michael A.
    Braunwald, Eugene
    CIRCULATION, 2016, 133 (13) : E463 - E463
1234